Genedrive PLC (GDR)

Industry Diagnostics & Research


This stock can be held in an Investment ISA, SIPP and Investment Account
Sell

0.80p

Buy

0.90p

arrow-down-0.0445p (-5.24%)

Prices updated at 19 Dec 2025, 14:07 GMT
| Prices minimum 15 mins delay
|
Prices in GBX

Genedrive PLC is a holding company engaged in molecular diagnostics business. The company is organised into operating divisions – Preclinical Research Services, Pharmacogenomic Services, and Diagnostics.

Income statement

20242025
332,000764,000
--
-5m-5m
-1,600.00-704.19
-7m-5m
-7m-5m
Sales, General and administrative2m2m
Interest expenses12,000-
Provision for income taxes-675,000-195,000
Operating expenses6m6m
Income before taxes-8m-5m
Net income available to common shareholders-7m-5m
-0.0216-0.009
Net interest income-548,000-46,000
Advertising and promotion--
Net investment income, net--
Realised capital gains (losses), net--
Total benefits, claims and expenses--
Earnings per share (diluted)-0.0216-0.009
Free cash flow per share-0.0201-0.0097
Book value/share0.00990.003
Debt equity ratio--

Balance sheet

20242025
Current assets7m3m
Current liabilities1m1m
Total capital5m1m
Total debt19,000-
Total equity5m1m
Total non current liabilities--
Loans--
Total assets7m3m
Total liabilities--
Cash and cash equivalents5m1m
Common stock543m625m

Cash flow

20242025
Cash at beginning of period3m5m
Cash dividends paid--
-4m-5m
Investments (gains) losses1,00020,000
5m1m
Net income--
-4m-5m
-29,000-23,000
The figures shown in the tables are quoted in the currency of the stock selected.
Please note that past performance is not a reliable indicator of future returns. Please use the interactive graph for benchmark comparison.


Important Information

Investment values, and income from investments, can go down as well as up, so you may get back less than you invest. This is not a personal recommendation for a specific investment. If you're not sure which investments are suitable for you, consult Fidelity's advisers or another authorised financial adviser. The information contained herein: is proprietary to Morningstar and/or its content providers; may not be copied or distributed; and is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.
© Copyright 2025 Morningstar. All rights reserved.